Unraveling Hematopoiesis through the Lens of Genomics.

Cell

Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA. Electronic address:

Published: September 2020

AI Article Synopsis

Similar Publications

Bone marrow hematopoietic injury encompasses a range of pathological conditions that disrupt the normal function of the hematopoietic system, primarily through the impaired production and differentiation of bone marrow hematopoietic cells. Key pathogenic mechanisms include aging, radiation damage, chemical induction, infection and inflammation, and cross-talk with non-hematopoietic diseases. These pathological factors often lead to myelosuppression and myeloid skewing.

View Article and Find Full Text PDF

Studying the Role of HOX Genes in Thrombocyte Development.

Methods Mol Biol

January 2025

Department of Biological Sciences, University of North Texas, Denton, TX, USA.

In our laboratory, we study thrombopoiesis and hemostasis using zebrafish as a model organism to unravel the mechanisms of differentiation and development of thrombocytes. We have shown in our earlier work that thrombocytes are functional equivalents of platelets and have transcriptional machinery similar to megakaryocytes. We recently found evidence that hox genes play a role in their development.

View Article and Find Full Text PDF

Hematopoiesis is a process by which all blood cells are formed. The mechanisms controlling it have been studied for decades. Surprisingly, while hematopoietic stem cells are among the most extensively studied stem cell types, the complete understanding of how they are regulated during development, adulthood, or in non-homeostatic conditions remains elusive.

View Article and Find Full Text PDF

Inflammatory form of Waldenström macroglobulinemia (iWM) predicts outcomes after immuno-chemotherapy and Bruton tyrosine kinase inhibitors, but its origin is unknown. Here, we unravel increased clonal hematopoiesis in patients with iWM (61% vs 23% in noninflammatory WM), suggesting a contribution of environmental cells to iWM.

View Article and Find Full Text PDF
Article Synopsis
  • * The disease presents symptoms like anemia and splenomegaly, with treatment options including JAK inhibitors (like Ruxolitinib) and other supportive therapies, while allogeneic stem cell transplantation is the only potential cure for eligible patients.
  • * Advances in Spatially Resolved Transcriptomics (SRT) allow for detailed analysis of gene expression in tissues, enhancing our understanding of the tumor microenvironment and cellular interactions in MF.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!